Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US aesthetic energy-based device market will grow moderately through 2027, driven primarily by an increasing number of aesthetically conscious patients in the country, as well as the industry's strong emphasis on advertising and marketing initiatives, new product launches and improvements, and strong clinical data.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for multiapplication systems and single-application systems in the US across a 10-year period.
With a number of major competitors having merged with or been acquired by other competitors in recent years, consolidation has been an important competitive strategy in this market.
What are the most significant mergers and acquisitions that have occurred in this market in recent years?
Among which companies are acquisitions most frequent? Which companies represent the most common acquisition targets?
How will these changes impact the market and competitive landscape?
A growing portion of noncore physicians are looking to supplement their revenues with procedures that use aesthetic energy-based devices.
What type of procedures will be most impacted by this demand?
How can competitors capitalize on this shift in customer segment and market demand?
Acne treatments, noninvasive fat reduction, tattoo removal, pigmented lesion removal, and skin resurfacing treatments will grow rapidly through 2027.
What physician types are performing these procedures? What settings are these procedures being performed in?
The FDA has warned device manufacturers to stop marketing energy-based devices for off-label use in vaginal rejuvenation.
How will this FDA warning impact the market?
What strategies can companies adopt to maintain a competitive position in the market?
Already a Client? Log in to access this report.
Raghav Tangri is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London. Follow Raghav on Twitter:@rtangri_DRG